IMGN : Summary for ImmunoGen, Inc. - Yahoo Finance

U.S. Markets closed

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.48+0.05 (+2.06%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close2.43
Bid2.36 x 1000
Ask2.52 x 400
Day's Range2.38 - 2.49
52 Week Range1.51 - 10.08
Avg. Volume2,061,919
Market Cap216.51M
PE Ratio (TTM)-1.39
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire6 hours ago

    ImmunoGen Announces Departure of Sandra Poole

    ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Sandra Poole, Executive Vice President, Technical Operations and Commercial Development, will leave the Company at the end of January to pursue other opportunities.

  • Why ImmnoGen, Inc. Jumped Higher Today
    Motley Fool19 days ago

    Why ImmnoGen, Inc. Jumped Higher Today

    The biotech leaps ahead for no apparent reason.

  • Accesswire20 days ago

    Latest Reports on Stocks to Watch: Inotek Pharmaceuticals and ImmunoGen

    NEW YORK, NY / ACCESSWIRE / January 4, 2017 / U.S. markets posted impressive after a tumultuous start to 2016. The Dow Industrials posted its worst-ever 5-day period to being the year with a 6.2 percent ...